Glenmark Launches New Pump-Pack Adapalene Gel in US OTC Market
Glenmark Pharmaceuticals has launched new pump-pack versions of its over-the-counter Adapalene Gel USP, 0.1, in the US market through its subsidiary Glenmark Therapeutics. Available in 15-gram and 45-gram sizes, the product is marketed as comparable to the active ingredient in Differin Gel 0.1, a leading acne treatment. The launch aims to enhance consumer convenience and expand Glenmark's dermatology portfolio. The product is listed on Amazon and Walmart.com, with the US OTC Differin Gel market valued at approximately $45.8 million annually.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 38/100.
Outlets measured: thefinancialexpress, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 6 Oct, 04:12 am. Other outlets followed.
- 1